10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2016 | |||
Consolidated Statement of Cash Flows | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 17, 2017) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Cash Flow From (Used in) Operating Activities: | |||
| Net earnings | $ 1,400 | 4,423 | 2,284 |
| Adjustments to reconcile earnings to net cash from operating activities - | |||
| Depreciation | 803 | 871 | 918 |
| Amortization of intangible assets | 550 | 601 | 630 |
| Share-based compensation | 310 | 292 | 246 |
| Impact of currency devaluation | 480 | ||
| Investing and financing (gains) losses, net | 86 | (18) | 69 |
| Amortization of bridge financing fees | 165 | ||
| Net loss on extinguishment of debt | 18 | ||
| Gain on sale of discontinued operations | (25) | (2,840) | |
| Mylan N.V. equity investment adjustment | 947 | ||
| Gain on sale of Mylan N.V. shares | (207) | ||
| Trade receivables | (177) | (171) | (195) |
| Inventories | (98) | (257) | (297) |
| Prepaid expenses and other assets | 113 | 57 | 30 |
| Trade accounts payable and other liabilities | (652) | (742) | (225) |
| Income taxes | (699) | 957 | 197 |
| Net Cash From Operating Activities | 3,203 | 2,966 | 3,675 |
| Cash Flow From (Used in) Investing Activities: | |||
| Acquisitions of property and equipment | (1,121) | (1,110) | (1,077) |
| Acquisitions of businesses and technologies, net of cash acquired | (80) | (235) | (3,317) |
| Proceeds from business dispositions | 25 | 230 | 5 |
| Proceeds from the sale of Mylan N.V. shares | 2,290 | ||
| Purchases of investment securities | (2,823) | (4,933) | (1,507) |
| Proceeds from sales of investment securities | 3,709 | 4,112 | 5,624 |
| Other | 42 | 52 | 70 |
| Net Cash From (Used in) Investing Activities | (248) | 406 | (202) |
| Cash Flow From (Used in) Financing Activities: | |||
| Proceeds from issuance of (repayments of) short-term debt and other | (1,767) | (1,281) | 1,343 |
| Proceeds from issuance of long-term debt and debt with maturities over 3 months | 14,934 | 2,485 | |
| Repayments of long-term debt and debt with maturities over 3 months | (12) | (57) | (577) |
| Payment of bridge financing fees | (170) | ||
| Acquisition and contingent consideration payments related to business acquisitions | (25) | (17) | (400) |
| Purchases of common shares | (522) | (2,237) | (2,195) |
| Proceeds from stock options exercised, including income tax benefit | 248 | 314 | 429 |
| Dividends paid | (1,539) | (1,443) | (1,342) |
| Net Cash From (Used in) Financing Activities | 11,147 | (2,236) | (2,742) |
| Effect of exchange rate changes on cash and cash equivalents | (483) | (198) | (143) |
| Net (Decrease) Increase in Cash and Cash Equivalents | 13,619 | 938 | 588 |
| Cash and Cash Equivalents, Beginning of Year | 5,001 | 4,063 | |
| Cash and Cash Equivalents, End of Year | 18,620 | 5,001 | 4,063 |
| Supplemental Cash Flow Information: | |||
| Income taxes paid | 620 | 631 | 448 |
| Interest paid | 181 | 166 | 146 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |